News Conference News TCT 2017 TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More Shelley Wood October 20, 2017
News Daily News Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor L.A. McKeown July 26, 2017
News Daily News TAVR Equivalent to Surgery in Real-World Practice, New Analysis Shows Michael O'Riordan July 17, 2017
News Conference News TVT 2017 Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base Michael O'Riordan June 17, 2017
Presentation TVT 2017 After PARTNER 2A/S3i and SURTAVI, What Is the Role of Surgery in Intermediate-Risk AS Patients? Presenter: David J. Cohen, Jeffrey J. Popma, Vinod H. Thourani June 16, 2017
News Conference News ACC 2017 SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients Todd Neale March 17, 2017
News Daily News Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib Todd Neale March 15, 2017
News Daily News Closer Look at SAVR Patients in PARTNER 2A Reveals a Quarter Also Had Additional Surgeries Shelley Wood January 27, 2017
News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Features Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más Shelley Wood December 30, 2016
News Daily News TAVR: Miracle for Some, but No Improvements in Quality of Life for Others Yael L. Maxwell December 22, 2016
News Opinion Editor's Corner TCT 2016 My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway Shelley Wood November 07, 2016
News Conference News TCT 2016 Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients Todd Neale November 02, 2016
Presentation TCT 2016 Intermediate-Risk Studies I: Synthesis of the PARTNER 2A and the Sapien 3 Intermediate-Risk Trials Presenter: Patrick T. O'Gara, Alec S. Vahanian, Susheel K. Kodali October 30, 2016
News Daily News New ‘Rapid Recommendations’ Tackle TAVR in Patients at Low-to-Intermediate Risk Todd Neale September 29, 2016
News Conference News PCR London Valves 2016 TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients Shelley Wood September 20, 2016
News Daily News Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe Michael O'Riordan September 20, 2016